Journal of Cancer Research and Therapeutics Close
 

Figure 2: Random-effects model of hazard ratio (95% CI) of overall survival (OS) associated with angiogenesis inhibitors (AIs)-containing regimens versus non-AIs-containing regimens

Figure 2: Random-effects model of hazard ratio (95% CI) of overall survival (OS) associated with angiogenesis inhibitors (AIs)-containing regimens versus non-AIs-containing regimens